Global Immunology Market By Drug Class (Monoclonal Antibody (mAb), Immunosuppressants, and Others), By Application (Psoriatic Arthritis, Rheumatoid Arthritis, Plaque Psoriasis, Inflammatory Bowel Disease, Ankylosing Spondylitis, and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Table of Contents

• 1. Executive Summary
  • 1.1. Definition
  • 1.2. Market Snapshot
  • 1.3. Market Overview
  • 1.4. Segment Overview
  • 1.5. Regional Overview
  • 1.6. Competitive Landscape
  • 1.7. Taxonomy
• 2. Global Market Overview
  • 2.1. Global Market Insights and Industry Overview
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunities
    • 2.2.4. Key Immunology Market Trends
  • 2.3. Regulatory Framework
  • 2.4. Opportunity Map Analysis
  • 2.5. Opportunity Orbits
  • 2.6. PESTLE Analysis
  • 2.7. PORTER’S Five Force Analysis
  • 2.8. Drivers & Restraints Impact Analysis
  • 2.9. Value Chain Analysis
    • 2.9.1. List of Raw Materials Suppliers
    • 2.9.2. List of Immunology Manufacturers
    • 2.9.3. List of Dealer/Distributors
  • 2.10. Regional Market Share and BPS Analysis
  • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
• 3. Global Immunology Market Analysis and Forecast, By Segment, 2020-2034
  • 3.1. Key Findings
  • 3.2. Global Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  • 3.3. Global Immunology Market Attractiveness Analysis, By Drug Class
    • 3.3.1. Monoclonal Antibody (mAb)
      • 3.3.1.1. Insights
      • 3.3.1.2. Key Takeaways
    • 3.3.2. Immunosuppressants
      • 3.3.2.1. Insights
      • 3.3.2.2. Key Takeaways
    • 3.3.3. Others
      • 3.3.3.1. Insights
      • 3.3.3.2. Key Takeaways
  • 3.4. Global Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 3.5. Global Immunology Market Attractiveness Analysis, By Application
    • 3.5.1. Rheumatoid Arthritis
      • 3.5.1.1. Insights
      • 3.5.1.2. Key Takeaways
    • 3.5.2. Psoriatic Arthritis
      • 3.5.2.1. Insights
      • 3.5.2.2. Key Takeaways
    • 3.5.3. Plaque Psoriasis
      • 3.5.3.1. Insights
      • 3.5.3.2. Key Takeaways
    • 3.5.4. Inflammatory Bowel Disease
      • 3.5.4.1. Insights
      • 3.5.4.2. Key Takeaways
    • 3.5.5. Ankylosing Spondylitis
      • 3.5.5.1. Insights
      • 3.5.5.2. Key Takeaways
    • 3.5.6. Others
      • 3.5.6.1. Insights
      • 3.5.6.2. Key Takeaways
  • 3.6. Global Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 3.7. Global Immunology Market Attractiveness Analysis, By Distribution Channel
    • 3.7.1. Hospital Pharmacies
      • 3.7.1.1. Insights
      • 3.7.1.2. Key Takeaways
    • 3.7.2. Online Pharmacies
      • 3.7.2.1. Insights
      • 3.7.2.2. Key Takeaways
    • 3.7.3. Retail Pharmacies
      • 3.7.3.1. Insights
      • 3.7.3.2. Key Takeaways
• 4. Global Immunology Market Analysis and Forecast, By Region, 2020-2034
  • 4.1. Key Findings
  • 4.2. Global Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    • 4.2.1. North America
      • 4.2.1.1. Regional Insights
    • 4.2.2. Europe
      • 4.2.2.1. Regional Insights
    • 4.2.3. Asia Pacific
      • 4.2.3.1. Regional Insights
    • 4.2.4. Latin America
      • 4.2.4.1. Regional Insights
    • 4.2.5. Middle East & Africa
      • 4.2.5.1. Regional Insights
  • 4.3. Global Immunology Market Attractiveness Analysis, By Region
• 5. North America Immunology Market Analysis and Forecast, 2020-2034
  • 5.1. Key Findings
  • 5.2. North America Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  • 5.3. North America Immunology Market Attractiveness Analysis, By Drug Class
  • 5.4. North America Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 5.5. North America Immunology Market Attractiveness Analysis, By Application
  • 5.6. North America Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 5.7. North America Immunology Market Attractiveness Analysis, By Distribution Channel
  • 5.8. North America Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 5.9. North America Immunology Market Attractiveness Analysis, By Country
    • 5.9.1. The US
    • 5.9.2. Canada
• 6. Europe Immunology Market Analysis and Forecast, 2020-2034
  • 6.1. Key Findings
  • 6.2. Europe Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  • 6.3. Europe Immunology Market Attractiveness Analysis, By Drug Class
  • 6.4. Europe Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 6.5. Europe Immunology Market Attractiveness Analysis, By Application
  • 6.6. Europe Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 6.7. Europe Immunology Market Attractiveness Analysis, By Distribution Channel
  • 6.8. Europe Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 6.9. Europe Immunology Market Attractiveness Analysis, By Country
    • 6.9.1. Germany
    • 6.9.2. The UK
    • 6.9.3. France
    • 6.9.4. Spain
    • 6.9.5. Italy
    • 6.9.6. Russia
    • 6.9.7. Netherland
    • 6.9.8. Rest of Europe
• 7. Asia Pacific Immunology Market Analysis and Forecast, 2020-2034
  • 7.1. Key Findings
  • 7.2. Asia Pacific Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  • 7.3. Asia Pacific Immunology Market Attractiveness Analysis, By Drug Class
  • 7.4. Asia Pacific Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 7.5. Asia Pacific Immunology Market Attractiveness Analysis, By Application
  • 7.6. Asia Pacific Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 7.7. Asia Pacific Immunology Market Attractiveness Analysis, By Distribution Channel
  • 7.8. Asia Pacific Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 7.9. Asia Pacific Immunology Market Attractiveness Analysis, By Country
    • 7.9.1. China
    • 7.9.2. Japan
    • 7.9.3. South Korea
    • 7.9.4. India
    • 7.9.5. Australia
    • 7.9.6. New Zealand
    • 7.9.7. Singapore
    • 7.9.8. Thailand
    • 7.9.9. Vietnam
    • 7.9.10. Rest of Asia Pacific
• 8. Latin America Immunology Market Analysis and Forecast, 2020-2034
  • 8.1. Key Findings
  • 8.2. Latin America Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  • 8.3. Latin America Immunology Market Attractiveness Analysis, By Drug Class
  • 8.4. Latin America Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 8.5. Latin America Immunology Market Attractiveness Analysis, By Application
  • 8.6. Latin America Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 8.7. Latin America Immunology Market Attractiveness Analysis, By Distribution Channel
  • 8.8. Latin America Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 8.9. Latin America Immunology Market Attractiveness Analysis, By Country
    • 8.9.1. Brazil
    • 8.9.2. Mexico
    • 8.9.3. Rest of Latin America
• 9. Middle East & Africa Immunology Market Analysis and Forecast, 2020-2034
  • 9.1. Key Findings
  • 9.2. Middle East & Africa Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  • 9.3. Middle East & Africa Immunology Market Attractiveness Analysis, By Drug Class
  • 9.4. Middle East & Africa Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 9.5. Middle East & Africa Immunology Market Attractiveness Analysis, By Application
  • 9.6. Middle East & Africa Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 9.7. Middle East & Africa Immunology Market Attractiveness Analysis, By Distribution Channel
  • 9.8. Middle East & Africa Immunology Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 9.9. Middle East & Africa Immunology Market Attractiveness Analysis, By Country
    • 9.9.1. South Africa
    • 9.9.2. Saudi Arabia
    • 9.9.3. UAE
    • 9.9.4. Rest of Middle East & Africa
• 10. Competitive Landscape & Company Profiles
  • 10.1. Market Competition Scenario Analysis, By Company
    • 10.1.1. Key Takeaways
  • 10.2. Overview of Major Market Players
  • 10.3. Competitor Landscape
  • 10.4. Strategic Mapping
  • 10.5. Company Life Cycle Analysis
  • 10.6. Company Market Share Analysis
  • 10.7. Company Profiles
    • 10.7.1. Sandoz
      • 10.7.1.1. Company Details
      • 10.7.1.2. Business Overview
      • 10.7.1.3. Product Portfolio
      • 10.7.1.4. Financial Insights
      • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.1.6. SWOT Analysis
      • 10.7.1.7. Geographic Footprint
    • 10.7.2. Novartis AG
      • 10.7.2.1. Company Details
      • 10.7.2.2. Business Overview
      • 10.7.2.3. Product Portfolio
      • 10.7.2.4. Financial Insights
      • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.2.6. SWOT Analysis
      • 10.7.2.7. Geographic Footprint
    • 10.7.3. Janssen Global Services, LLC
      • 10.7.3.1. Company Details
      • 10.7.3.2. Business Overview
      • 10.7.3.3. Product Portfolio
      • 10.7.3.4. Financial Insights
      • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.3.6. SWOT Analysis
      • 10.7.3.7. Geographic Footprint
    • 10.7.4. Eli Lilly and Company
      • 10.7.4.1. Company Details
      • 10.7.4.2. Business Overview
      • 10.7.4.3. Product Portfolio
      • 10.7.4.4. Financial Insights
      • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.4.6. SWOT Analysis
      • 10.7.4.7. Geographic Footprint
    • 10.7.5. Amgen Inc
      • 10.7.5.1. Company Details
      • 10.7.5.2. Business Overview
      • 10.7.5.3. Product Portfolio
      • 10.7.5.4. Financial Insights
      • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.5.6. SWOT Analysis
      • 10.7.5.7. Geographic Footprint
    • 10.7.6. ALLERGAN
      • 10.7.6.1. Company Details
      • 10.7.6.2. Business Overview
      • 10.7.6.3. Product Portfolio
      • 10.7.6.4. Financial Insights
      • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.6.6. SWOT Analysis
      • 10.7.6.7. Geographic Footprint
    • 10.7.7. AbbVie Inc.
      • 10.7.7.1. Company Details
      • 10.7.7.2. Business Overview
      • 10.7.7.3. Product Portfolio
      • 10.7.7.4. Financial Insights
      • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.7.6. SWOT Analysis
      • 10.7.7.7. Geographic Footprint
• 11. Methodology and Data Source
  • 11.1. Methodology/Research Approach
  • 11.2. Market Size Estimation
  • 11.3. Market Breakdown and Data Triangulation
  • 11.4. Data Source
  • 11.5. Secondary Sources
  • 11.6. Primary Sources
  • 11.7. Appendix
  • 11.8. Disclaimer

List of Tables

• Table 1. Global Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 2. Global Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 3. Global Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 4. Global Immunology Market Value (US$ Mn), By Region, 2020-2034
• Table 5. North America Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 6. North America Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 7. North America Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 8. North America Immunology Market Value (US$ Mn), By Country, 2020-2034
• Table 9. The US Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 10. The US Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 11. The US Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 12. Canada Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 13. Canada Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 14. Canada Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 15. Europe Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 16. Europe Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 17. Europe Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 18. Europe Immunology Market Value (US$ Mn), By Country, 2020-2034
• Table 19. Germany Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 20. Germany Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 21. Germany Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 22. The UK Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 23. The UK Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 24. The UK Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 25. France Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 26. France Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 27. France Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 28. Spain Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 29. Spain Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 30. Spain Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 31. Italy Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 32. Italy Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 33. Italy Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 34. Russia Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 35. Russia Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 36. Russia Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 37. Netherland Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 38. Netherland Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 39. Netherland Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 40. Rest of Europe Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 41. Rest of Europe Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 42. Rest of Europe Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 43. Asia Pacific Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 44. Asia Pacific Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 45. Asia Pacific Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 46. Asia Pacific Immunology Market Value (US$ Mn), By Country, 2020-2034
• Table 47. China Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 48. China Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 49. China Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 50. India Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 51. India Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 52. India Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 53. Japan Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 54. Japan Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 55. Japan Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 56. South Korea Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 57. South Korea Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 58. South Korea Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 59. Australia Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 60. Australia Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 61. Australia Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 62. New Zealand Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 63. New Zealand Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 64. New Zealand Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 65. Singapore Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 66. Singapore Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 67. Singapore Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 68. Thailand Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 69. Thailand Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 70. Thailand Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 71. Vietnam Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 72. Vietnam Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 73. Vietnam Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 74. Rest of Asia Pacific Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 75. Rest of Asia Pacific Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 76. Rest of Asia Pacific Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 77. Latin America Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 78. Latin America Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 79. Latin America Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 80. Latin America Immunology Market Value (US$ Mn), By Country, 2020-2034
• Table 81. Brazil Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 82. Brazil Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 83. Brazil Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 84. Mexico Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 85. Mexico Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 86. Mexico Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 87. Rest of Latin America Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 88. Rest of Latin America Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 89. Rest of Latin America Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 90. Middle East & Africa Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 91. Middle East & Africa Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 92. Middle East & Africa Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 93. Middle East & Africa Immunology Market Value (US$ Mn), By Country, 2020-2034
• Table 94. South Africa Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 95. South Africa Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 96. South Africa Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 97. Saudi Arabia Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 98. Saudi Arabia Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 99. Saudi Arabia Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 100. UAE Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 101. UAE Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 102. UAE Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 103. Rest of Middle East & Africa Immunology Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 104. Rest of Middle East & Africa Immunology Market Value (US$ Mn), By Application, 2020-2034
• Table 105. Rest of Middle East & Africa Immunology Market Value (US$ Mn), By Distribution Channel, 2020-2034

List of Figures

• Figure 1. Global Immunology Market Snapshot: Market Value (US$ Mn), 2020-2034
• Figure 2. Opportunity Map
• Figure 3. Opportunity Orbit
• Figure 4. Regional Market Share and BPS Analysis in Immunology Market
• Figure 5. Global Immunology Market Analysis, By Drug Class, 2020, 2024 and 2034
• Figure 6. Global Immunology Market Attractiveness Analysis, By Drug Class
• Figure 7. Global Immunology Market Analysis, By Application, 2020, 2024 and 2034
• Figure 8. Global Immunology Market Attractiveness Analysis, By Application
• Figure 9. Global Immunology Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 10. Global Immunology Market Attractiveness Analysis, By Distribution Channel
• Figure 11. Global Immunology Market Analysis, By Region, 2020, 2024 and 2034
• Figure 12. Global Immunology Market Attractiveness Analysis, By Region
• Figure 13. North America Immunology Market Analysis, By Drug Class, 2020, 2024 and 2034
• Figure 14. North America Immunology Market Attractiveness Analysis, By Drug Class
• Figure 15. North America Immunology Market (US$ Mn), by Monoclonal Antibody (mAb), 2020-2034
• Figure 16. North America Immunology Market (US$ Mn), by Immunosuppressants, 2020-2034
• Figure 17. North America Immunology Market (US$ Mn), by Others, 2020-2034
• Figure 18. North America Immunology Market Analysis, By Application, 2020, 2024 and 2034
• Figure 19. North America Immunology Market Attractiveness Analysis, By Application
• Figure 20. North America Immunology Market (US$ Mn), by Rheumatoid Arthritis, 2020-2034
• Figure 21. North America Immunology Market (US$ Mn), by Psoriatic Arthritis, 2020-2034
• Figure 22. North America Immunology Market (US$ Mn), by Plaque Psoriasis, 2020-2034
• Figure 23. North America Immunology Market (US$ Mn), by Inflammatory Bowel Disease, 2020-2034
• Figure 24. North America Immunology Market (US$ Mn), by Ankylosing Spondylitis, 2020-2034
• Figure 25. North America Immunology Market (US$ Mn), by Others, 2020-2034
• Figure 26. North America Immunology Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 27. North America Immunology Market Attractiveness Analysis, By Distribution Channel
• Figure 28. North America Immunology Market (US$ Mn), by Hospital Pharmacies, 2020-2034
• Figure 29. North America Immunology Market (US$ Mn), by Online Pharmacies, 2020-2034
• Figure 30. North America Immunology Market (US$ Mn), by Retail Pharmacies, 2020-2034
• Figure 31. North America Immunology Market Analysis, By Country, 2020, 2024 and 2034
• Figure 32. North America Immunology Market Attractiveness Analysis, By Country
• Figure 33. Europe Immunology Market Analysis, By Drug Class, 2020, 2024 and 2034
• Figure 34. Europe Immunology Market Attractiveness Analysis, By Drug Class
• Figure 35. Europe Immunology Market (US$ Mn), by Monoclonal Antibody (mAb), 2020-2034
• Figure 36. Europe Immunology Market (US$ Mn), by Immunosuppressants, 2020-2034
• Figure 37. Europe Immunology Market (US$ Mn), by Others, 2020-2034
• Figure 38. Europe Immunology Market Analysis, By Application, 2020, 2024 and 2034
• Figure 39. Europe Immunology Market Attractiveness Analysis, By Application
• Figure 40. Europe Immunology Market (US$ Mn), by Rheumatoid Arthritis, 2020-2034
• Figure 41. Europe Immunology Market (US$ Mn), by Psoriatic Arthritis, 2020-2034
• Figure 42. Europe Immunology Market (US$ Mn), by Plaque Psoriasis, 2020-2034
• Figure 43. Europe Immunology Market (US$ Mn), by Inflammatory Bowel Disease, 2020-2034
• Figure 44. Europe Immunology Market (US$ Mn), by Ankylosing Spondylitis, 2020-2034
• Figure 45. Europe Immunology Market (US$ Mn), by Others, 2020-2034
• Figure 46. Europe Immunology Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 47. Europe Immunology Market Attractiveness Analysis, By Distribution Channel
• Figure 48. Europe Immunology Market (US$ Mn), by Hospital Pharmacies, 2020-2034
• Figure 49. Europe Immunology Market (US$ Mn), by Online Pharmacies, 2020-2034
• Figure 50. Europe Immunology Market (US$ Mn), by Retail Pharmacies, 2020-2034
• Figure 51. Europe Immunology Market Analysis, By Country, 2020, 2024 and 2034
• Figure 52. Europe Immunology Market Attractiveness Analysis, By Country
• Figure 53. Asia Pacific Immunology Market Analysis, By Drug Class, 2020, 2024 and 2034
• Figure 54. Asia Pacific Immunology Market Attractiveness Analysis, By Drug Class
• Figure 55. Asia Pacific Immunology Market (US$ Mn), by Monoclonal Antibody (mAb), 2020-2034
• Figure 56. Asia Pacific Immunology Market (US$ Mn), by Immunosuppressants, 2020-2034
• Figure 57. Asia Pacific Immunology Market (US$ Mn), by Others, 2020-2034
• Figure 58. Asia Pacific Immunology Market Analysis, By Application, 2020, 2024 and 2034
• Figure 59. Asia Pacific Immunology Market Attractiveness Analysis, By Application
• Figure 60. Asia Pacific Immunology Market (US$ Mn), by Rheumatoid Arthritis, 2020-2034
• Figure 61. Asia Pacific Immunology Market (US$ Mn), by Psoriatic Arthritis, 2020-2034
• Figure 62. Asia Pacific Immunology Market (US$ Mn), by Plaque Psoriasis, 2020-2034
• Figure 63. Asia Pacific Immunology Market (US$ Mn), by Inflammatory Bowel Disease, 2020-2034
• Figure 64. Asia Pacific Immunology Market (US$ Mn), by Ankylosing Spondylitis, 2020-2034
• Figure 65. Asia Pacific Immunology Market (US$ Mn), by Others, 2020-2034
• Figure 66. Asia Pacific Immunology Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 67. Asia Pacific Immunology Market Attractiveness Analysis, By Distribution Channel
• Figure 68. Asia Pacific Immunology Market (US$ Mn), by Hospital Pharmacies, 2020-2034
• Figure 69. Asia Pacific Immunology Market (US$ Mn), by Online Pharmacies, 2020-2034
• Figure 70. Asia Pacific Immunology Market (US$ Mn), by Retail Pharmacies, 2020-2034
• Figure 71. Asia Pacific Immunology Market Analysis, By Country, 2020, 2024 and 2034
• Figure 72. Asia Pacific Immunology Market Attractiveness Analysis, By Country
• Figure 73. Latin America Immunology Market Analysis, By Drug Class, 2020, 2024 and 2034
• Figure 74. Latin America Immunology Market Attractiveness Analysis, By Drug Class
• Figure 75. Latin America Immunology Market (US$ Mn), by Monoclonal Antibody (mAb), 2020-2034
• Figure 76. Latin America Immunology Market (US$ Mn), by Immunosuppressants, 2020-2034
• Figure 77. Latin America Immunology Market (US$ Mn), by Others, 2020-2034
• Figure 78. Latin America Immunology Market Analysis, By Application, 2020, 2024 and 2034
• Figure 79. Latin America Immunology Market Attractiveness Analysis, By Application
• Figure 80. Latin America Immunology Market (US$ Mn), by Rheumatoid Arthritis, 2020-2034
• Figure 81. Latin America Immunology Market (US$ Mn), by Psoriatic Arthritis, 2020-2034
• Figure 82. Latin America Immunology Market (US$ Mn), by Plaque Psoriasis, 2020-2034
• Figure 83. Latin America Immunology Market (US$ Mn), by Inflammatory Bowel Disease, 2020-2034
• Figure 84. Latin America Immunology Market (US$ Mn), by Ankylosing Spondylitis, 2020-2034
• Figure 85. Latin America Immunology Market (US$ Mn), by Others, 2020-2034
• Figure 86. Latin America Immunology Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 87. Latin America Immunology Market Attractiveness Analysis, By Distribution Channel
• Figure 88. Latin America Immunology Market (US$ Mn), by Hospital Pharmacies, 2020-2034
• Figure 89. Latin America Immunology Market (US$ Mn), by Online Pharmacies, 2020-2034
• Figure 90. Latin America Immunology Market (US$ Mn), by Retail Pharmacies, 2020-2034
• Figure 91. Latin America Immunology Market Analysis, By Country, 2020, 2024 and 2034
• Figure 92. Latin America Immunology Market Attractiveness Analysis, By Country
• Figure 93. Middle East & Africa Immunology Market Analysis, By Drug Class, 2020, 2024 and 2034
• Figure 94. Middle East & Africa Immunology Market Attractiveness Analysis, By Drug Class
• Figure 95. Middle East & Africa Immunology Market (US$ Mn), by Monoclonal Antibody (mAb), 2020-2034
• Figure 96. Middle East & Africa Immunology Market (US$ Mn), by Immunosuppressants, 2020-2034
• Figure 97. Middle East & Africa Immunology Market (US$ Mn), by Others, 2020-2034
• Figure 98. Middle East & Africa Immunology Market Analysis, By Application, 2020, 2024 and 2034
• Figure 99. Middle East & Africa Immunology Market Attractiveness Analysis, By Application
• Figure 100. Middle East & Africa Immunology Market (US$ Mn), by Rheumatoid Arthritis, 2020-2034
• Figure 101. Middle East & Africa Immunology Market (US$ Mn), by Psoriatic Arthritis, 2020-2034
• Figure 102. Middle East & Africa Immunology Market (US$ Mn), by Plaque Psoriasis, 2020-2034
• Figure 103. Middle East & Africa Immunology Market (US$ Mn), by Inflammatory Bowel Disease, 2020-2034
• Figure 104. Middle East & Africa Immunology Market (US$ Mn), by Ankylosing Spondylitis, 2020-2034
• Figure 105. Middle East & Africa Immunology Market (US$ Mn), by Others, 2020-2034
• Figure 106. Middle East & Africa Immunology Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 107. Middle East & Africa Immunology Market Attractiveness Analysis, By Distribution Channel
• Figure 108. Middle East & Africa Immunology Market (US$ Mn), by Hospital Pharmacies, 2020-2034
• Figure 109. Middle East & Africa Immunology Market (US$ Mn), by Online Pharmacies, 2020-2034
• Figure 110. Middle East & Africa Immunology Market (US$ Mn), by Retail Pharmacies, 2020-2034
• Figure 111. Middle East & Africa Immunology Market Analysis, By Country, 2020, 2024 and 2034
• Figure 112. Middle East & Africa Immunology Market Attractiveness Analysis, By Country